{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:54:10Z","timestamp":1793858050570,"version":"4.6.1"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.neuroscience.2024.07.019","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T22:33:39Z","timestamp":1721342019000},"page":"52-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Mesenchymal stem cell therapy for Alzheimer\u2019s disease: A novel therapeutic approach for neurodegenerative diseases"],"prefix":"10.1016","volume":"555","author":[{"given":"Aditya","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshita","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.07.019_b0005","doi-asserted-by":"crossref","unstructured":"2022 Alzheimer\u2019s disease facts and figures, 2022. Alzheimer\u2019s Dement. 18, 700\u2013789.","DOI":"10.1002\/alz.12638"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/agm2.12216","article-title":"A consolidated review on stem cell therapy for treatment and management of Alzheimer's disease","volume":"5","author":"Ahmad","year":"2022","journal-title":"Aging Med. (Milton)"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5114\/aoms.2011.20612","article-title":"Tramiprosate in mild-to-moderate Alzheimer\u2019s disease \u2013 a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)","volume":"7","author":"Aisen","year":"2011","journal-title":"Arch. Med. Sci."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.07.019_b0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/153331750401900502","article-title":"Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury?","volume":"19","author":"Albensi","year":"2004","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"issue":"12","key":"10.1016\/j.neuroscience.2024.07.019_b0025","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jsps.2022.10.004","article-title":"An update on the novel and approved drugs for Alzheimer disease","volume":"30","author":"Alhazmi","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0030","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s11033-018-4499-7","article-title":"Stem cell therapy in Alzheimer\u2019s disease: possible benefits and limiting drawbacks","volume":"46","author":"Alipour","year":"2019","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0035","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s11033-018-4499-7","article-title":"Stem cell therapy in Alzheimer\u2019s disease: possible benefits and limiting drawbacks","volume":"46","author":"Alipour","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0045","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 5th ed. American Psychiatric Association, Washington, DC.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2174\/1567205012666150302154121","article-title":"Vanutidecridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer\u2019s disease: results from two phase 2 studies","volume":"12","author":"Arai","year":"2015","journal-title":"Curr. Alzheimer Res."},{"issue":"Suppl. 3","key":"10.1016\/j.neuroscience.2024.07.019_b0055","first-page":"8","article-title":"Navigating patients and caregivers through the course of Alzheimer\u2019s disease","volume":"67","author":"Aupperle","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/jpet.114.219352","article-title":"Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer\u2019s disease","volume":"352","author":"Baddeley","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(80)91004-5","article-title":"Polarity of the blood-brain barrier: distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells","volume":"192","author":"Betz","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0070","doi-asserted-by":"crossref","DOI":"10.33582\/2637-4927\/1002","article-title":"Alzheimer\u2019s disease: causes & treatment \u2013 a review","volume":"1","author":"Bhushan","year":"2018","journal-title":"Ann. Biotechnol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0075","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/brain\/awl063","article-title":"CSF amyloid-\u03b2-peptides in Alzheimer\u2019s disease, dementia with lewy bodies and Parkinson\u2019s disease dementia","volume":"129","author":"Bibl","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/stem.626","article-title":"The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells","volume":"29","author":"Bissonnette","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0085","unstructured":"Brauser, D., 2017. Two more phase 3 trials of Alzheimer\u2019s drug idalopirdine fail. Medscape. Available from: http:\/\/www.medscape.com\/viewarticle\/875632."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0090","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2174\/157015911798376352","article-title":"Chemical biology, molecular mechanism and clinical perspective of gamma-secretase modulators in Alzheimer\u2019s disease","volume":"9","author":"Bulic","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0095","first-page":"85","article-title":"The genetic relevance of human induced pluripotent stem cell-derived microglia to Alzheimer\u2019s disease and major neuropsychiatric disorders","volume":"5","author":"Butler","year":"2020","journal-title":"Mol Neuropsychiatry"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5966\/sctm.2016-0081","article-title":"Protein-induced pluripotent stem cells ameliorate cognitive dysfunction and reduce A\u03b2 deposition in a mouse model of Alzheimer\u2019s disease","volume":"6","author":"Cha","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00797","article-title":"Elucidating the interactive roles of glia in Alzheimer's disease using established and newly developed experimental models","volume":"9","author":"Chun","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0110","unstructured":"ClinicalTrials.gov Identifier: NCT01297218."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0115","unstructured":"Safety and exploratory efficacy study of NEUROSTEM\u00ae versus placebo in patients with Alzheimer\u2019s disease. ClinicalTrials.gov Identifier: NCT02054208."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0120","unstructured":"ClinicalTrials.gov Identifier: NCT02899091."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0125","unstructured":"A study to evaluate the safety and efficacy of AstroStem in treatment of Alzheimer\u2019s disease. ClinicalTrials.gov Identifier: NCT03117738."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0130","unstructured":"ClinicalTrials.gov Identifier: NCT03724136."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0135","unstructured":"A clinical trial to determine the safety and efficacy of hope biosciences autologous mesenchymal stem cell therapy (HB-adMSCs) for the treatment of Alzheimer\u2019s disease. ClinicalTrials.gov Identifier: NCT04228666."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0140","unstructured":"ClinicalTrials.gov Identifier: NCT04388982."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0145","unstructured":"ClinicalTrials.gov Identifier: NCT04482413."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.07.019_b0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/187152710791011991","article-title":"Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease","volume":"9","author":"Cole","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/srep31306","article-title":"Mesenchymal stem cells enhance nerve regeneration in a rat sciatic nerve repair and hindlimb transplant model","volume":"6","author":"Cooney","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mcn.2010.06.017","article-title":"Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid","volume":"45","author":"Cooper","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2174\/156720501107140815102453","article-title":"Overview of immunotherapy in Alzheimer's disease (AD) and mechanisms of IVIG neuroprotection in preclinical models of AD","volume":"11","author":"Counts","year":"2014","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000477122","article-title":"Bone marrow mesenchymal stem cell transplantation increases GAP-43 expression via ERK1\/2 and PI3K\/Akt pathways in intracerebral hemorrhage","volume":"42","author":"Cui","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0175","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1096\/fj.201700600R","article-title":"Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP\/PS1 mice","volume":"32","author":"Cui","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0180","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(16)00127-7","article-title":"Genetic variations underlying Alzheimer\u2019s disease: evidence from genome-wide association studies and beyond","volume":"15","author":"Cuyvers","year":"2016","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.neuroscience.2024.07.019_b0185","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.2174\/1389201021666201218130947","article-title":"Advances in stem cell therapy for brain diseases via the intranasal route","volume":"22","author":"Dali","year":"2021","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0190","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"CSH Perspect. Biol."},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2024.07.019_b0195","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.3727\/096368914X684970","article-title":"Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer\u2019s and Parkinson\u2019s disease","volume":"23","author":"Danielyan","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40263-019-00613-7","article-title":"A close look at BACE1 inhibitors for Alzheimer's disease treatment","volume":"33","author":"Das","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0205","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.4161\/hv.27882","article-title":"Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines","volume":"10","author":"Davtyan","year":"2014","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0210","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1074\/jbc.M117.807180","article-title":"Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-beta oligomers","volume":"293","author":"de Godoy","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-? Peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS Neurolog. Disord."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.07.019_b0220","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5497\/wjp.v4.i3.236","article-title":"Therapeutic targets and delivery challenges for Alzheimer\u2019s disease","volume":"4","author":"Desai","year":"2015","journal-title":"World J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0225","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1212\/WNL.0000000000009816","article-title":"Healthy lifestyle and the risk of Alzheimer dementia: findings from 2 longitudinal studies","volume":"95","author":"Dhana","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0230","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0235","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ecam\/nel071","article-title":"The use of herbal medicine in Alzheimer\u2019s disease-a systematic review","volume":"3","author":"Dos Santos-Neto","year":"2006","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010120","article-title":"Stem cell therapy for Alzheimer\u2019s disease: a scoping review for 2017\u20132022","volume":"11","author":"Duan","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00343","article-title":"Neurodegeneration and microtubule dynamics: death by a thousand cuts","volume":"9","author":"Dubey","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0250","unstructured":"DVC STEM. What are Mesenchymal Stem Cells? [Internet]. Available from: https:\/\/www.dvcstem.com\/post\/what-are-mesenchymal-stem-cells."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.07.019_b0255","first-page":"672","article-title":"Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: a comprehensive review","volume":"21","author":"Ebrahimi","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0260","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.physbeh.2018.11.034","article-title":"Dimethyloxalylglycine preconditioning enhances protective effects of bone marrow-derived mesenchymal stem cells in A\u03b2-induced Alzheimer disease","volume":"199","author":"Esmaeilzade","year":"2019","journal-title":"Physiol. Behav."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.07.019_b0265","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jcyt.2015.01.005","article-title":"Murine adipose-derived mesenchymal stromal cell vesicles: in vitro clues for neuroprotective and neuroregenerative approaches","volume":"17","author":"Farinazzo","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0270","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0275","doi-asserted-by":"crossref","DOI":"10.1186\/s42269-019-0078-x","article-title":"Stem cells as a promising therapeutic approach for Alzheimer\u2019s disease: a review","volume":"43","author":"Fouad","year":"2019","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0280","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1002\/jcp.26454","article-title":"Heat shock protein (Hsp) regulation by muscarinic acetyl-choline receptor (mAChR) activation in the rat hippocampus","volume":"233","author":"Frinchi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2013.10.043","article-title":"Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPSCs","volume":"557","author":"Fujiwara","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106142","article-title":"Exosomes released from bone-marrow stem cells ameliorate hippocampal neuronal injury through transferring miR-455-3p","volume":"31","author":"Gan","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00030","article-title":"Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer\u2019s disease","volume":"6","author":"Garcia","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00030","article-title":"Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer\u2019s disease","volume":"6","author":"Garcia","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0305","series-title":"Life after Diagnosis: Navigating Treatment, Care and Support","first-page":"1","author":"Gauthier","year":"2022"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0310","doi-asserted-by":"crossref","DOI":"10.1186\/1478-811X-12-23","article-title":"Signaling pathway cross talk in Alzheimer\u2019s disease","volume":"12","author":"Godoy","year":"2014","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0315","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"issue":"21","key":"10.1016\/j.neuroscience.2024.07.019_b0320","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0325","article-title":"Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer\u2019s disease","volume":"12","author":"Guo","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0330","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3233\/JAD-140291","article-title":"A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer\u2019s dementia","volume":"42","author":"Haig","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0335","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0340","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3727\/096368915X687561","article-title":"Stemness enhancement of human neural stem cells following bone marrow MSC coculture","volume":"24","author":"Haragopal","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0345","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/1565","article-title":"Genetic dissection of Alzheimer\u2019s disease and related dementias: amyloid and its relationship to tau","volume":"1","author":"Hardy","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0350","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7834421","article-title":"Mesenchymal stem cell therapy for Alzheimer\u2019s disease","volume":"2021","author":"Hern\u00e1ndez","year":"2021","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00155","article-title":"Understanding the pathophysiological actions of tau oligomers: a critical review of current electrophysiological approaches","volume":"13","author":"Hill","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0360","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0365","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1358-y","article-title":"The functions and clinical application potential of exosomes derived from adipose mesenchymal stem cells: a comprehensive review","volume":"10","author":"Hong","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0370","article-title":"Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer\u2019s disease donor as a model for investigating AD-associated gene regulatory networks","volume":"16","author":"Hossini","year":"2015","journal-title":"BMC Genom"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0375","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jneumeth.2016.03.017","article-title":"Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells","volume":"266","author":"Hu","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0380","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-017-0355-7","article-title":"Drug candidates in clinical trials for Alzheimer\u2019s disease","volume":"24","author":"Hung","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.07.019_b0385","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.nic.2005.09.009","article-title":"Pathophysiology of Alzheimer's disease","volume":"15","author":"Imbimbo","year":"2005","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43)","volume":"13","author":"Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00564","article-title":"Therapeutic effects of transplanted exosomes containing miR-29b to a rat model of Alzheimer\u2019s Disease","volume":"14","author":"Jahangard","year":"2020","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.07.019_b0400","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/cbin.11500","article-title":"Potential role of NGF, BDNF and their receptors in oligodendrocytes differentiation from neural stem cell - an in-vitro study","volume":"45","author":"Jaldeep","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0405","article-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease","volume":"2","author":"Jaturapatporn","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.07.019_b0410","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3892\/ol.2016.4857","article-title":"Therapeutic potential of human amniotic membrane-derived mesenchymal stem cells in APP transgenic mice","volume":"12","author":"Jiao","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0415","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1874467208666150928153511","article-title":"Stem cell therapy and immunological rejection in animal models","volume":"9","author":"Jin","year":"2016","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0420","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3892\/br.2014.405","article-title":"Interaction between neural stem cells and bone marrow derived-mesenchymal stem cells during differentiation","volume":"3","author":"Ju","year":"2015","journal-title":"Biomed. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-180035","article-title":"A new perspective in utilizing MMP-9 as a therapeutic target for Alzheimer\u2019s disease and type 2 diabetes mellitus","volume":"64","author":"Kaminari","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0430","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41434-019-0101-8","article-title":"MiR-21 derived from the exosomes of MSCs regulates the death and differentiation of neurons in patients with spinal cord injury","volume":"26","author":"Kang","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0435","article-title":"Safety of technique and procedure of stromal vascular fraction therapy: from liposuction to cell administration","volume":"2020","author":"Karina","year":"2020","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0440","doi-asserted-by":"crossref","DOI":"10.1038\/srep01197","article-title":"Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes","volume":"3","author":"Katsuda","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0445","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS beta-amyloid in animal models and in Alzheimer\u2019s disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102113","article-title":"Recent advancement in therapeutic strategies for Alzheimer\u2019s disease: insights from clinical trials","volume":"92","author":"Khan","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"16","key":"10.1016\/j.neuroscience.2024.07.019_b0455","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1016\/j.febslet.2010.07.028","article-title":"Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro","volume":"584","author":"Kim","year":"2010","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.07.019_b0460","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/cdd.2011.140","article-title":"Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-beta plaques","volume":"19","author":"Kim","year":"2012","journal-title":"Cell Death Differ."},{"issue":"20","key":"10.1016\/j.neuroscience.2024.07.019_b0465","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1089\/scd.2014.0487","article-title":"GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer\u2019s disease model","volume":"24","author":"Kim","year":"2015","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-200219","article-title":"Mesenchymal stem cell therapy and Alzheimer\u2019s disease: current status and future perspectives","volume":"77","author":"Kim","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0475","article-title":"Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer\u2019s disease model","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0480","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trci.2015.06.007","article-title":"Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase 1 clinical trial","volume":"1","author":"Kim","year":"2015","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0485","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000345615","article-title":"Introduction to stem cells and regenerative medicine","volume":"85","author":"Kolios","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0490","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3233\/JAD-150393","article-title":"Histamine H3 receptor antagonists for Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"48","author":"Kubo","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0495","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0500","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00487","article-title":"NGF-dependent changes in ubiquitin homeostasis trigger early cholinergic degeneration in cellular and animal AD-model","volume":"12","author":"Latina","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0505","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0243-6","article-title":"Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-beta using BV2 microglial cells and APP\/PS1 transgenic mice","volume":"12","author":"Latta","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0510","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.stem.2010.11.028","article-title":"Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K\/Akt-dependant manner","volume":"8","author":"Le Belle","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.neuroscience.2024.07.019_b0515","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbrc.2014.03.051","article-title":"Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo","volume":"446","author":"Lee","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.07.019_b0520","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2174\/156720510792231739","article-title":"Bone marrow-derived mesenchymal stem cells attenuate amyloid beta- induced memory impairment and apoptosis by inhibiting neuronal cell death","volume":"7","author":"Lee","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0525","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-015-0035-6","article-title":"Human neural stem cells alleviate Alzheimer-like pathology in a mouse model","volume":"10","author":"Lee","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0530","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3727\/096368912X638964","article-title":"Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in the mouse with ibotenic acid-induced cognitive dysfunction","volume":"21","author":"Lee","year":"2012","journal-title":"Cell Transplant."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.07.019_b0535","first-page":"629","article-title":"Killing two birds with one stone: the multifunctional roles of mesenchymal stem cells in the treatment of neurodegenerative and muscle diseases","volume":"33","author":"Lee","year":"2018","journal-title":"Histol. Histopathol."},{"issue":"7082","key":"10.1016\/j.neuroscience.2024.07.019_b0540","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0545","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.expneurol.2013.04.001","article-title":"Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control","volume":"247","author":"Liang","year":"2013","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0550","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7150\/thno.16911","article-title":"Heparin improves BMSC cell therapy: anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy","volume":"7","author":"Liao","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0555","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxx002","article-title":"Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer\u2019s disease","volume":"29","author":"Liew","year":"2017","journal-title":"Int. Immunol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0560","unstructured":"Lilly Halts, 2013. Phase 2 Trial of BACE inhibitor due to liver toxicity [Internet]. Available from: http:\/\/www.alzforum.org\/news\/research-news\/lilly-halts-phase-2-trial-bace-inhibitor-due-liver-toxicity."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0565","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8878412","article-title":"Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces aberrant tau phosphorylation in an Alzheimer disease model","volume":"2020","author":"Lim","year":"2020","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0570","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000430356","article-title":"Therapeutic effects of transplantation of As-MiR-937- expressing mesenchymal stem cells in murine model of Alzheimer\u2019s disease","volume":"37","author":"Liu","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0575","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.2565","article-title":"Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits","volume":"31","author":"Liu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0580","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Sig. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.07.019_b0585","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4252\/wjsc.v12.i8.787","article-title":"Stem cell therapy for Alzheimer's disease","volume":"12","author":"Liu","year":"2020","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0590","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jnr.20148","article-title":"Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact?","volume":"77","author":"Lu","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040497","article-title":"Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review","volume":"17","author":"Lucke-Wold","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0600","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9628536","article-title":"Challenges and controversies in human mesenchymal stem cell therapy","volume":"2019","author":"Lukomska","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0605","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15283\/ijsc.2014.7.2.118","article-title":"Comparison of mesenchymal stem cell markers in multiple human adult stem cells","volume":"7","author":"Maleki","year":"2014","journal-title":"Int. J. Stem Cells"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0610","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0197-4580(95)00025-A","article-title":"Tau domains, phosphorylation, and interactions with microtubules","volume":"16","author":"Mandelkow","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0615","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8590578","article-title":"The role of reactive oxygen species in the pathogenesis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease: a mini review","volume":"2016","author":"Manoharan","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0620","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer\u2019s disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuroscience.2024.07.019_b0625","article-title":"Mitochondrial calcium: effects of its imbalance in disease","volume":"11","author":"Matuz-Mares","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"10","key":"10.1016\/j.neuroscience.2024.07.019_b0630","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102523","article-title":"Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs)","volume":"20","author":"Mazini","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104509","article-title":"Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer\u2019s disease","volume":"130","author":"Mendon\u00e7a","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0640","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/hmg\/ddu064","article-title":"The familial Alzheimer\u2019s disease APPV717I mutation alters APP processing and tau expression in iPSC-derived neurons","volume":"23","author":"Muratore","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.07.019_b0645","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/nan.12319","article-title":"Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP\/PS1 Alzheimer mice","volume":"43","author":"Naaldijk","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0650","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1021\/bc400005m","article-title":"In vivo study on the survival of neural stem cells transplanted into the rat brain with a collagen hydrogel that incorporates laminin-derived polypeptides","volume":"24","author":"Nakaji-Hirabayashi","year":"2013","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0655","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67460-1","article-title":"Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer\u2019s disease model by increasing the expression of microRNA-146a in hippocampus","volume":"10","author":"Nakano","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0660","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.febslet.2013.05.010","article-title":"The amyloid precursor protein: a biochemical enigma in brain development, function and disease","volume":"587","author":"Nalivaeva","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0665","unstructured":"Nature Cell to unveil stem cell drug for Alzheimer\u2019s disease. KBR Bio. http:\/\/www.koreabiomed.com\/news\/articleView.html?idxno=919 (accessed November 26, 2020)."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0670","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0169-328X(86)90033-1","article-title":"Identification of CDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2","volume":"1","author":"Neve","year":"1986","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113706","article-title":"Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer\u2019s disease","volume":"341","author":"Neves","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0680","first-page":"523","article-title":"Prevalence and incidence of Alzheimer\u2019s disease in Europe: A meta-analysis","volume":"32","author":"Niu","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0685","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1002\/jcb.26726","article-title":"The extracellular vesicles-derived from mesenchymal stromal cells: a new therapeutic option in regenerative medicine","volume":"119","author":"Nooshabadi","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0690","doi-asserted-by":"crossref","first-page":"16825","DOI":"10.1073\/pnas.1108077108","article-title":"Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice","volume":"108","author":"Nori","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0695","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3727\/096368910X539083","article-title":"Cotransplantation of mouse neural stem cells (mNSCs) with adipose tissue-derived mesenchymal stem cells improves mNSC survival in a rat spinal cord injury model","volume":"20","author":"Oh","year":"2011","journal-title":"Cell Transplant."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0700","article-title":"Clinical trials in Alzheimer\u2019s disease: a hurdle in the path of remedy","volume":"2020","author":"Oxford","year":"2020","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0705","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-\u0392-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0710","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3245935","article-title":"Tau-centric targets and drugs in clinical development for the treatment of Alzheimer\u2019s disease","author":"Panza","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"11","key":"10.1016\/j.neuroscience.2024.07.019_b0715","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.07.019_b0720","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s12272-016-0799-4","article-title":"Activin A secreted by human mesenchymal stem cells induces neuronal development and neurite outgrowth in an in vitro model of Alzheimer\u2019s disease: neurogenesis induced by MSCs via activin A","volume":"39","author":"Park","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0725","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jnr.23182","article-title":"Human adipose tissue-derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice","volume":"91","author":"Park","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0730","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1383-2","article-title":"Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury","volume":"16","author":"Peruzzaro","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0735","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2014.10.029","article-title":"CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid","volume":"302","author":"Porrini","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0740","unstructured":"Axovant Unveils New Data Analysis Showing Addition of Intepirdine to Standard Therapy May Help People with Alzheimer\u2019s Disease Maintain Independence Longer. PR Newswire. 2016. Available from: http:\/\/www.prnewswire.com\/news-releases\/axovant-unveils-new-data-analysis-showing-addition-of-intepirdine-to-standard-therapy-may-help-people-with-alzheimers-disease-maintain-independence-longer-300376136.html."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.07.019_b0745","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuropharm.2011.10.024","article-title":"EVP-6124, a novel and selective alpha7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of alpha7 nicotinic acetylcholine receptors","volume":"62","author":"Prickaerts","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0750","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-020-00199-x","article-title":"Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer\u2019s disease: a meta-analytic review on potential mechanisms","volume":"9","author":"Qin","year":"2020","journal-title":"Transl. Neurodegen."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0755","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.2147\/JIR.S327538","article-title":"Functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer\u2019s disease: inhibition of neuroinflammation","volume":"14","author":"Qin","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0760","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ame2.12207","article-title":"Stem cell therapy for Alzheimer's disease: an overview of experimental models and reality","volume":"5","author":"Qin","year":"2022","journal-title":"Animal Model. Exp. Med."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0765","unstructured":"Rare but severe side effects sideline some phase 3 encenicline trials [Internet]. Available from: http:\/\/www.alzforum.org\/news\/research-news\/rare-severe-side-effects-sideline-some-phase-3-encenicline-trials."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0770","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11051398","article-title":"An insight into cellular and molecular mechanisms underlying the pathogenesis of neurodegeneration in Alzheimer\u2019s disease","volume":"11","author":"Ratan","year":"2023","journal-title":"Biomedicines"},{"issue":"38","key":"10.1016\/j.neuroscience.2024.07.019_b0775","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1523\/JNEUROSCI.3158-09.2009","article-title":"CD14 and toll-like receptors 2 and 4 are required for fibrillar A\u03b2-stimulated microglial activation","volume":"29","author":"Reed-Geaghan","year":"2009","journal-title":"J. Neurosci."},{"issue":"5\u20138","key":"10.1016\/j.neuroscience.2024.07.019_b0780","article-title":"Mesenchymal stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities, and future perspectives","volume":"98","author":"Regmi","year":"2019","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0785","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00317","article-title":"Potential effects of MSC-derived exosomes in neuroplasticity in Alzheimer\u2019s disease","volume":"12","author":"Reza-Zaldivar","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.07.019_b0790","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa109","article-title":"Alzheimer\u2019s disease neuroimaging initiative, anti-inflammatories in Alzheimer\u2019s disease\u2014potential therapy or spurious correlate?","volume":"2","author":"Rivers-Auty","year":"2020","journal-title":"Brain Commun."},{"issue":"17","key":"10.1016\/j.neuroscience.2024.07.019_b0795","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1021\/acschemneuro.3c00486","volume":"14","author":"Roy","year":"2023","journal-title":"ACS Chem. Nerosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.07.019_b0800","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and therapeutic potential of VEGF in the nervous system","volume":"89","author":"Ruiz de Almodovar","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0805","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","article-title":"Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer\u2019s disease","volume":"132","author":"Sadleir","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.07.019_b0810","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s12035-014-9051-8","article-title":"Bone marrow-derived endothelial progenitor cells protect against scopolamine-induced Alzheimer-like pathological aberrations","volume":"53","author":"Safar","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0815","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/5584_2018_214","article-title":"Stem cells in Alzheimer\u2019s disease: current standing and future challenges","volume":"1079","author":"Salem","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0820","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","article-title":"Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice","volume":"28","author":"Santamaria","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0825","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0830","doi-asserted-by":"crossref","DOI":"10.1186\/s13041-023-00997-0","article-title":"Circadian rhythms in the blood-brain barrier: impact on neurological disorders and stress responses","volume":"16","author":"Schurhoff","year":"2023","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0835","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0840","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer\u2019s disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0845","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0850","doi-asserted-by":"crossref","first-page":"15285","DOI":"10.18632\/aging.203088","article-title":"Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer\u2019s disease in rat models via the microRNA-29c-3p\/BACE1 axis and the Wnt\/\u03b2-catenin pathway","volume":"13","author":"Sha","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.07.019_b0855","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/jpet.120.000324","article-title":"Stem cell therapies in Alzheimer's disease: applications for disease modeling","volume":"377","author":"Si","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.07.019_b0860","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.07.019_b0865","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0870","article-title":"Immunotherapy for Alzheimer\u2019s disease: targeting \u03b2-amyloid and beyond","volume":"11","author":"Song","year":"2022","journal-title":"TranslNeurodegener"},{"issue":"5","key":"10.1016\/j.neuroscience.2024.07.019_b0875","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.mayocp.2019.01.001","article-title":"Mesenchymal stromal cell therapies for neurodegenerative diseases","volume":"94","author":"Staff","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0880","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072301","article-title":"Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy","volume":"8","author":"Theunis","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.07.019_b0885","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.dnarep.2005.03.002","article-title":"Role of mitochondrial DNA in toxic responses to oxidative stress","volume":"5","author":"Van Houten","year":"2006","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0890","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-016-0189-7","article-title":"Bapineuzumab for mild to moderate Alzheimer\u2019s disease in two global, randomized, phase 3 trials","volume":"8","author":"Vandenberghe","year":"2016","journal-title":"Alzheimers Res. Ther."},{"issue":"17","key":"10.1016\/j.neuroscience.2024.07.019_b0895","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174272","article-title":"Neurodegeneration and neuro-regeneration-Alzheimer's disease and stem cell therapy","volume":"20","author":"Vasic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0900","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.07.019_b0905","first-page":"1240","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"BiochimBiophysActa"},{"key":"10.1016\/j.neuroscience.2024.07.019_b0910","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active Abeta immunotherapy with CAD106 in patients with Alzheimer\u2019s disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0915","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.07.019_b0920","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4103\/1673-5374.131596","article-title":"Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer\u2019s disease mice","volume":"9","author":"Yan","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0925","doi-asserted-by":"crossref","DOI":"10.1186\/scrt227","article-title":"Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an A\u03b2PP\/PS1 transgenic mouse model","volume":"4","author":"Yang","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0930","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2017.08.017","article-title":"Developmental suppression of forebrain trkA receptors and attentional capacities in aging rats: a longitudinal study","volume":"335","author":"Yegla","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0935","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0940","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3233\/JAD-190817","article-title":"Transplantation of mesenchymal stem cells improves Amyloid-\u03b2 pathology by modifying microglial function and suppressing oxidative stress","volume":"72","author":"Yokokawa","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.07.019_b0945","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4235\/agmr.21.0079","article-title":"Cardiovascular complications of acetylcholinesterase inhibitors in patients with Alzheimer's disease: a narrative review","volume":"25","author":"Young","year":"2021","journal-title":"Ann. Geriatr. Med. Res."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0950","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.stemcr.2015.09.010","article-title":"ESC-derived basal forebrain cholinergic neurons ameliorate the cognitive symptoms associated with Alzheimer\u2019s disease in mouse models","volume":"5","author":"Yue","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0955","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1039\/C5BM00383K","article-title":"Strategies for transporting nanoparticles across the blood-brain barrier","volume":"4","author":"Zhang","year":"2016","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0960","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1089\/scd.2020.0103","article-title":"Human induced pluripotent stem cell-derived neural cells from Alzheimer\u2019s disease patients exhibited different susceptibility to oxidative stress","volume":"29","author":"Zhang","year":"2020","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.neuroscience.2024.07.019_b0965","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00140","article-title":"Transplantation of human menstrual blood-derived mesenchymal stem cells alleviates Alzheimer\u2019s Disease-Like Pathology in APP\/PS1 Transgenic Mice","volume":"11","author":"Zhao","year":"2018","journal-title":"Front. Mol. Neurosci."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224003324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224003324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:00:15Z","timestamp":1751374815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224003324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":193,"alternative-id":["S0306452224003324"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.07.019","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cell therapy for Alzheimer\u2019s disease: A novel therapeutic approach for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 IBRO. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}